Jubilant Life Sep '11 sales at Rs 631.03 crore

Published on Wed, Nov 02, 2011 at 11:18 |  Source : Moneycontrol.com

4193 Investors following Jubilant Life. Share this News with them.
0
0
Share on Tumblr
Jubilant Life Sep '11 sales at Rs 631.03 crore

ALSO READ

Jubilant Life Sciences has reported a sales turnover of Rs 631.03 crore and a net profit of Rs 5.00 crore for the quarter ended Sep '11.
For the quarter ended Sep 2010 the sales turnover was Rs 672.66 crore and net profit was Rs 97.85 crore.
Quarterly Results of Jubilant Life Sciences-------- in Rs. Cr. --------
Sep '10Jun '11Sep '11
Sales Turnover672.66618.75631.03
Other Income0.492.352.29
Total Income673.15621.10633.32
Total Expenses534.32494.39520.42
Operating Profit138.34124.36110.61
Profit On Sale Of Assets------
Profit On Sale Of Investments------
Gain/Loss On Foreign Exchange------
VRS Adjustment------
Other Extraordinary Income/Expenses------
Total Extraordinary Income/Expenses7.10-5.36-41.60
Tax On Extraordinary Items------
Net Extra Ordinary Income/Expenses------
Gross Profit138.83126.71112.90
Interest8.6330.0135.99
PBDT137.3094.0235.31
Depreciation25.6927.6829.21
Depreciation On Revaluation Of Assets------
PBT111.6166.346.10
Tax13.7612.451.10
Net Profit97.8553.895.00
Prior Years Income/Expenses------
Depreciation for Previous Years Written Back/ Provided------
Dividend------
Dividend Tax------
Dividend (%)------
Earnings Per Share6.163.380.31
Book Value------
Equity15.8815.9315.93
Reserves------
Face Value1.001.001.00
Source : Dion Global Solutions Limited

  

Trending News

Business News

2TB drives offer best value for money
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

On Facebook IPO Morgan Stanley Speculation Of 'Nefarious Activity' Around IPO Untrue

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 23:16

Clash of Spain and ECB worrying investors: Verstrate

- in FII View

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!